Synthesis of New Branched 2-Nitroimidazole as a Hypoxia Sensitive Linker for Ligand-Targeted Drugs of Paclitaxel-Reference-Cited by-同舟云学术

Synthesis of New Branched 2-Nitroimidazole as a Hypoxia Sensitive Linker for Ligand-Targeted Drugs of Paclitaxel

Published:2018-08-08 Issue:8 Volume:3 Page:8813-8818
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Zhang Qiumeng¹,Jin Chen¹,Yu Jiahui¹^ORCID,Lu Wei¹^ORCID

Affiliation:

1. Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, P. R. China

Funder

Shanghai Science and Technology Council

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.8b01208

Reference23 articles.

1. Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

2. Paclitaxel in cancer therapy

3. Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance

4. Advances in the Use of Taxanes in the Adjuvant Therapy of Breast Cancer

5. Ligand-Targeted Drug Delivery

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring polymeric nanocarriers for hypoxia-specific drug release: Insights into design and applications in clinics;Chemical Engineering Journal;2024-09

2. Recent progress in stimuli-responsive polymeric micelles for targeted delivery of functional nanoparticles;Advances in Colloid and Interface Science;2024-08

3. Recent Advances in the Application of Nitro(het)aromatic Compounds for Treating and/or Fluorescent Imaging of Tumor Hypoxia;Molecules;2024-07-25

4. Hypoxia-activated and improved cell uptake near-infrared fluorescent probe for precise guiding surgical resection;Nano Today;2024-06

5. Enhanced tumor specific drug release by hypoxia sensitive dual-prodrugs based on 2-nitroimidazole;Bioorganic & Medicinal Chemistry Letters;2023-10